Last update July 16, 2017
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Lornoxicam is also known as
Lornoxicam in other languages or writings:
Lornoxicam belongs to this group or family:
Main tradenames from several countries containing Lornoxicam in its composition:
|T½||3 - 4||hours|
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Non-steroidal anti-inflammatory drug with analgesic properties related to oxycodone group. It is the only one with short half-life span.
At latest update relevant published data on its excretion into breast milk were not found.
Its high binding capacity to plasma proteins makes its excretion into breastmilk very unlikely. Another drug from the same group and same degree of protein binding capacity, Piroxicam (see specific info), has a negligible excretion into milk.
Until more data on this drug is available, a safer and known alternative may be preferable, especially in case of nursing infants who are less than one month old or a premature babies.
See below the information of this related product: